Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Change in Cash (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Change in Cash data on record, last reported at -$17.3 million in Q4 2025.

  • For Q4 2025, Change in Cash fell 213.43% year-over-year to -$17.3 million; the TTM value through Dec 2025 reached -$11.6 million, down 133.98%, while the annual FY2025 figure was -$2.6 million, 108.78% down from the prior year.
  • Change in Cash reached -$17.3 million in Q4 2025 per PAHC's latest filing, down from $4.7 million in the prior quarter.
  • Across five years, Change in Cash topped out at $22.2 million in Q4 2021 and bottomed at -$31.2 million in Q1 2023.
  • Average Change in Cash over 5 years is $1.0 million, with a median of $2.8 million recorded in 2022.
  • Peak YoY movement for Change in Cash: skyrocketed 2464.96% in 2021, then crashed 1102.99% in 2024.
  • A 5-year view of Change in Cash shows it stood at $22.2 million in 2021, then crashed by 135.38% to -$7.9 million in 2022, then decreased by 29.59% to -$10.2 million in 2023, then skyrocketed by 249.63% to $15.2 million in 2024, then plummeted by 213.43% to -$17.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Cash were -$17.3 million in Q4 2025, $4.7 million in Q3 2025, and $7.7 million in Q2 2025.